ResMed | Pasivo Circulante



Current Liabilities Cambio Fecha
Ansell USD 423.4M 200K 2024-06
AtriCure USD 73.42M 1.01M 2024-12
Baxter International USD 6.51B 311M 2024-12
Cochlear AUD 631.5M 114.1M 2024-06
Cooper Companies USD 999.6M 23.2M 2025-01
CSL USD 4.95B 232M 2024-06
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Fisher Paykel Healthcare NZD 372.9M 12.1M 2024-09
Globus Medical USD 855.91M 37.85M 2024-12
Haemonetics USD 253.23M 20.71M 2024-12
Hologic USD 1B 34.8M 2024-12
Idexx Laboratories USD 1.07B 58.69M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
Masimo USD 617.7M 19.9M 2024-12
Medtronic USD 11.84B 355M 2025-01
Philips EUR 8.15B 615M 2024-12
Ramsay Health Care AUD 3.72B 465.1M 2024-12
ResMed USD 851.96M 52.12M 2024-12
Sigma Healthcare AUD 701.53M 330.25M 2024-07
Sonic Healthcare AUD 2.23B 92.84M 2024-12
Steris USD 891.12M 85.64M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12



ResMed Pasivo Circulante - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.